Purified Human Pancreatic Islets, CIT Culture Media with Lisofylline or Exenatide.

J Ansite, Nancy D. Bridges(National Institute of Allergy and Infectious Diseases), X Zhang(Emory University), Stéphane Carpentier(Université Fédérale de Toulouse Midi-Pyrénées), Elizabeth Holbrook, Juan Antonio Moreno(Instituto Maimónides de Investigación Biomédica de Córdoba), Christian P. Larsen(Emory University Hospital), James F. Markmann(University of Pennsylvania), Tatsuya Kin(University of Alberta), Nicole A. Turgeon(Emory University), Christine W. Czarniecki, Xunrong Luo(Duke University), JS Hutchinson(Emory University), M. Sears(Gladstone Institutes), L Wang, E Holbrook(Emory University), J J Wilhelm, C Liu, Z Min, S Deng(Massachusetts General Hospital), B Barbaro, D Brandhorst, J Avila(Emory University), J S Goldstein, E Linetsky, T Wilson, T Templeton, J Battle, J Moreno, G Szot, D O'Gorman, D Feddersen, J Willits, J Lei, G Putz, A Khan, C Ricordi, T Gilmore, K K Papas, A Friberg, B Begley(Emory University), J Cano(Emory University), K McElvaney, J Cano, J Lei(Massachusetts General Hospital), X Chen, S Deng, David D. Webster(Emory University), A N Balamurugan

PubMed

January 1, 2017

Cited by 0

Related Papers

Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways

|Nature|1996|1.5k

Therapeutic siRNA silencing in inflammatory monocytes in mice

|Nature Biotechnology|2011|837

4-1BB Costimulatory Signals Preferentially Induce CD8+ T Cell Proliferation and Lead to the Amplification In Vivo of Cytotoxic T Cell Responses

|The Journal of Experimental Medicine|1997|802

Rational Development of LEA29Y (belatacept), a High-Affinity Variant of CTLA4-Ig with Potent Immunosuppressive Properties

|American Journal of Transplantation|2005|714

Heterologous immunity provides a potent barrier to transplantation tolerance

|Journal of Clinical Investigation|2003|571